U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C21H38N.Cl
Molecular Weight 339.986
Optical Activity NONE
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BENZODODECINIUM CHLORIDE

SMILES

[Cl-].CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1

InChI

InChIKey=JBIROUFYLSSYDX-UHFFFAOYSA-M
InChI=1S/C21H38N.ClH/c1-4-5-6-7-8-9-10-11-12-16-19-22(2,3)20-21-17-14-13-15-18-21;/h13-15,17-18H,4-12,16,19-20H2,1-3H3;1H/q+1;/p-1

HIDE SMILES / InChI

Molecular Formula C21H38N
Molecular Weight 304.5331
Charge 1
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity NONE

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Benzododecinium, a quaternary ammonium compound, is an antiseptic agent and disinfectant. Benzododecinium is used as preservative in different pharmaceutical formulations. Thus, the dispenser of Timoptol-LA, used for the treatment of patients with ocular hypertension, contains benzododecinium bromide as a preservative. It is used as preservative and the corneal permeability enhancer in formulation. Benzododecinium is effective against gram-positive microbes.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
PubMed

PubMed

TitleDatePubMed
The use of quaternary ammonium disinfectants selects for persisters at high frequency from some species of non-tuberculous mycobacteria and may be associated with outbreaks of soft tissue infections.
2010-12
Short-term comparative study of the effects of preserved and unpreserved topical levofloxacin on the human ocular surface.
2010-12
Tolerability and effectiveness of preservative-free dorzolamide-timolol (preservative-free COSOPT) in patients with open-angle glaucoma or ocular hypertension.
2010-07-21
[Optimization of benzalkonium chloride concentration in 0.0015% tafluprost ophthalmic solution from the points of ocular surface safety and preservative efficacy].
2010-06
Sorption of quaternary ammonium compounds to municipal sludge.
2010-04
Biofouling control using microparticles carrying a biocide.
2010
In situ forming polymeric drug delivery systems.
2009-05
Characterization of occupational exposures to cleaning products used for common cleaning tasks--a pilot study of hospital cleaners.
2009-03-27
Surface and volume properties of dodecylethyldimethylammonium bromide and benzyldimethyldodecylammonium bromide I. Surface properties of dodecylethyldimethylammonium bromide and benzyldimethyldodecylammonium bromide.
2009-03-15
Synthesis of macroporous thermosensitive hydrogels: a novel method of controlling pore size.
2009-03-03
Surface and volume properties of dodecylethyldimethylammonium bromide and benzyldimethyldodecylammonium bromide: II. Volumetric properties of dodecylethyldimethylammonium bromide and benzyldimethyldodecylammonium bromide.
2009-02-15
Instrument processing with lauryl dimethyl benzyl ammonium bromide: a challenge for patient safety.
2008-10
Speciation of scandium and gallium in soil.
2008-09
Measuring quaternary ammonium cleaning agents with ion selective electrodes.
2006-06-16
The influence of cholesterol on the interaction between N-dodecyl-N,N-dimethyl-N-benzylammonium halides and phosphatidylcholine bilayers.
2006-05-30
[Inactivation of mycobacteria by disinfectants with a tuberculocidal label].
2006-05
Molecular mechanism and thermodynamics study of plasmid DNA and cationic surfactants interactions.
2006-04-11
Release characteristics of anionic drug compounds from liquid crystalline gels. Part II. The effects of ion pairing and buffering on the passive delivery of anionic drugs across non-rate-limiting membranes.
2006-03-27
Architecture of the hydrophobic and hydrophilic layers as found from crystal structure analysis of N-benzyl-N,N-dimethylalkylammonium bromides.
2005-10-01
Identification of benzalkonium chloride in commercial grapefruit seed extracts.
2005-09-21
Water purification from organic pollutants by optimized micelle-clay systems.
2005-04-01
[Preformulation studies of potential drug XIX M: partition coefficient].
2005-03
Adverse drug reactions in Canada. Hematologic reactions to sterol and sterolin-containing products.
2004-08
Analysis of benzyldimethyldodecylammonium bromide in chemical disinfectants by liquid chromatography and capillary electrophoresis.
2004-06-11
Effect of alcohol addition to the aqueous phase on the thermal effects of micellization of cationic benzyldimethyldodecylammonium bromide and its adsorption onto porous and nonporous silicas.
2004-04-15
Sterol and sterolin-containing products: hematologic adverse reactions.
2004-04-13
Interaction between N-dodecyl-N,N-dimethyl-N-benzylammonium halides and phosphatidylcholine bilayers-the effect of counterions.
2003-04
Bactericidal treatment of raw cotton as the method of byssinosis prevention.
2003-02-07
Speciation of vanadium in soil.
2003-01-02
Mikrocalorimetric studies on the interaction of N-dodecyl-N,N-dimethyl-N-benzylammonium halides with phosphatidylcholine bilayers: a counterion effect.
2002
Controlled drug release from gels using surfactant aggregates. II. Vesicles formed from mixtures of amphiphilic drugs and oppositely charged surfactants.
2001-11
Counterion effects on interaction of amphiphilic quaternary ammonium salts with model membranes.
2001-06-26
Quaternary ammoniums and other preservatives' contribution in oxidative stress and apoptosis on Chang conjunctival cells.
2001-03
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Curator's Comment: The design proposed the optimized batch by selecting the independent variables as gellan gum (0.55% w/v), carbopol 934P (0.35% w/v) and benzododecenium bromide (0.013% w/v) to achieve the maximum viscosity
Ophthalmic use: The 25 uL of test sample was instilled in the lower conjunctival sac of eye and holded for 10 seconds.
Route of Administration: Topical
In Vitro Use Guide
Curator's Comment: The mechanism of action of benzyldimethyldodecylammonium chloride (Benzododecinium chloride) was assessed against Pseudomonas fluorescens.
The MIC was found to be 20 mg/L and the MBC was 10 mg/L
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:23:06 GMT 2025
Edited
by admin
on Mon Mar 31 18:23:06 GMT 2025
Record UNII
Y5A751G47H
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BENZODODECINIUM CHLORIDE
INN   MART.   WHO-DD  
INN  
Official Name English
NSC-85508
Preferred Name English
N-TETRADECYL DIMETHYL ETHYLBENZYL AMMONIUM CHLORIDE
Systematic Name English
BENZODODECINIUM CHLORIDE [MART.]
Common Name English
BENZYLDODECYLDIMETHYLAMMONIUM CHLORIDE
Systematic Name English
BENZYLDIMETHYLDODECYLAMMONIUM CHLORIDE
Systematic Name English
Benzododecinium chloride [WHO-DD]
Common Name English
benzododecinium chloride [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C28394
Created by admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
CFR 21 CFR 172.165
Created by admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
Code System Code Type Description
INN
1172
Created by admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
PRIMARY
NSC
85508
Created by admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
PRIMARY
MESH
C015163
Created by admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
PRIMARY
NCI_THESAURUS
C79712
Created by admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
PRIMARY
DAILYMED
Y5A751G47H
Created by admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
PRIMARY
FDA UNII
Y5A751G47H
Created by admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
PRIMARY
PUBCHEM
8753
Created by admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
PRIMARY
EPA CompTox
DTXSID2040787
Created by admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
PRIMARY
ChEMBL
CHEMBL1907001
Created by admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
PRIMARY
SMS_ID
100000086369
Created by admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
PRIMARY
EVMPD
SUB05759MIG
Created by admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
PRIMARY
RXCUI
1311592
Created by admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
PRIMARY RxNorm
CAS
139-07-1
Created by admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
PRIMARY
CHEBI
167208
Created by admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
PRIMARY
ECHA (EC/EINECS)
205-351-5
Created by admin on Mon Mar 31 18:23:06 GMT 2025 , Edited by admin on Mon Mar 31 18:23:06 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY